Zobrazeno 1 - 10
of 26
pro vyhledávání: '"RX Menezes"'
Publikováno v:
Revista de Saúde Pública, Vol 33, Iss 4, Pp 329-333 (1999)
INTRODUCTION: The evolution of virulence in host-parasite relationships has been the subject of several publications. In the case of HIV virulence, some authors suggest that the evolution of HIV virulence correlates with the rate of acquisition of ne
Externí odkaz:
https://doaj.org/article/96db43501c6740c7a2d11e696bdcaa6f
Autor:
Raymundo Soares Azevedo, RX Menezes, Heráclito Barbosa Carvalho, D P Ferreira, Leila Strazza, Eduardo Massad, Dirce Maria Trevisan Zanetta, Marcelo Nascimento Burattini
Publikováno v:
International Journal of STD & AIDS. 10:98-104
In order to study the prevalence of HIV and related risky behaviours among disadvantaged youth, we interviewed and bled, between December 1994 and April 1995, 1122 young males and 93 young females who were serving time in FEBEM, a state institution t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97fbcb0b1353ad798d1bab6da50857b5
https://doi.org/10.1258/0956462991913718
https://doi.org/10.1258/0956462991913718
Publikováno v:
Revista de Saúde Pública, Vol 33, Iss 4, Pp 329-333 (1999)
INTRODUCTION: The evolution of virulence in host-parasite relationships has been the subject of several publications. In the case of HIV virulence, some authors suggest that the evolution of HIV virulence correlates with the rate of acquisition of ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4512ce80d269db67846d1d9e1841e0
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89101999000400002
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89101999000400002
Autor:
R. S. Azevedo-Neto, L. F. Lopes, Eduardo Massad, Marcelo Nascimento Burattini, RX Menezes, Francisco Antonio Bezerra Coutinho
Publikováno v:
Mathematical and Computer Modelling. 28:21-29
We propose a dynamic model to study the impact of the introduction of crack-cocaine among illicit drug users, considering the population divided into susceptible to drug use, crack-cocaine users, intravenous drug users, and users of both types of dru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65c43060950f433166abd49116b141fe
https://doi.org/10.1016/s0895-7177(98)00095-8
https://doi.org/10.1016/s0895-7177(98)00095-8
Autor:
Ciwinska M; VIB-KULeuven Centre for Cancer Biology, Department of Oncology, Leuven, Belgium., Messal HA; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hristova HR; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Lutz C; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bornes L; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Chalkiadakis T; Centre for Molecular Medicine, UMC Utrecht, Utrecht, the Netherlands., Harkes R; Bioimaging Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Langedijk NSM; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hutten SJ; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Menezes RX; Biostatistics Centre and Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Jonkers J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Prekovic S; Centre for Molecular Medicine, UMC Utrecht, Utrecht, the Netherlands., Simons BD; Gurdon Institute, University of Cambridge, Cambridge, UK. bds10@cam.ac.uk.; Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, UK. bds10@cam.ac.uk.; Department of Applied Mathematics and Theoretical Physics, Centre for Mathematical Sciences, University of Cambridge, Cambridge, UK. bds10@cam.ac.uk., Scheele CLGJ; VIB-KULeuven Centre for Cancer Biology, Department of Oncology, Leuven, Belgium. colinda.scheele@kuleuven.be., van Rheenen J; Division of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands. j.v.rheenen@nki.nl.
Publikováno v:
Nature [Nature] 2024 Sep; Vol. 633 (8028), pp. 198-206. Date of Electronic Publication: 2024 Sep 04.
Autor:
van Breugel ME; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., van Kruijsbergen I; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Mittal C; Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, USA; Department of Molecular Biology and Genetics, Biotechnology Building, Cornell University, Ithaca, NY 14853, USA., Lieftink C; Division of Molecular Carcinogenesis and Robotics and Screening Center, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Brouwer I; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Division of Gene Regulation, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066 CX, the Netherlands., van den Brand T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Hoekman L; Proteomics Facility, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Menezes RX; Biostatistics Centre and Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., van Welsem T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Del Cortona A; VIB-KU Leuven Center for Microbiology, KU Leuven, 3001 Heverlee-Leuven, Belgium., Malik M; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Beijersbergen RL; Division of Molecular Carcinogenesis and Robotics and Screening Center, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands., Lenstra TL; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Division of Gene Regulation, Netherlands Cancer Institute, Oncode Institute, Amsterdam 1066 CX, the Netherlands., Verstrepen KJ; VIB-KU Leuven Center for Microbiology, KU Leuven, 3001 Heverlee-Leuven, Belgium., Pugh BF; Department of Molecular Biology and Genetics, Biotechnology Building, Cornell University, Ithaca, NY 14853, USA., van Leeuwen F; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam 1066 CX, the Netherlands; Department of Medical Biology, Amsterdam UMC, University of Amsterdam, Amsterdam 1105 AZ, the Netherlands. Electronic address: fred.v.leeuwen@nki.nl.
Publikováno v:
Molecular cell [Mol Cell] 2023 Dec 07; Vol. 83 (23), pp. 4205-4221.e9. Date of Electronic Publication: 2023 Nov 22.
Autor:
van Gils N; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Verhagen HJMP; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Broux M; KU Leuven Center for Human Genetics, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Martiáñez T; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Denkers F; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Vermue E; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Rutten A; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Csikós T; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Demeyer S; KU Leuven Center for Human Genetics, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Çil M; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Al M; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Cools J; KU Leuven Center for Human Genetics, Leuven, Belgium.; VIB Center for Cancer Biology, Leuven, Belgium., Janssen JJWM; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands., Menezes RX; Department of Epidemiology and Biostatistics, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands., Smit L; Department of Hematology, Amsterdam UMC, location VUmc, Cancer Center Amsterdam, Amsterdam, the Netherlands.
Publikováno v:
IScience [iScience] 2022 Aug 25; Vol. 25 (9), pp. 105013. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).
Autor:
van Gils N; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Verhagen HJMP; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Rutten A; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Menezes RX; Department of Epidemiology and Biostatistics, Amsterdam UMC, Location VUmc, Amsterdam, The Netherlands., Tsui ML; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Vermue E; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Dekens E; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Brocco F; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Denkers F; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Kessler FL; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Ossenkoppele GJ; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Janssen JJWM; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and., Smit L; Department of Hematology, Amsterdam UMC, Location VUmc, Cancer Center Amsterdam, Amsterdam, The Netherlands; and.
Publikováno v:
Blood advances [Blood Adv] 2020 Dec 22; Vol. 4 (24), pp. 6368-6383.
Autor:
Verhagen HJMP; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., van Gils N; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Martiañez T; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., van Rhenen A; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Rutten A; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Denkers F; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., de Leeuw DC; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Smit MA; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Tsui ML; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., de Vos Klootwijk LLE; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Menezes RX; Department of Epidemiology and Biostatistics, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Çil M; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Roemer MGM; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Vermue E; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Heukelom S; Department of Radiology & Nuclear Medicine, Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Zweegman S; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Janssen JJWM; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Ossenkoppele GJ; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Schuurhuis GJ; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands., Smit L; Department of Hematology, Cancer Center Amsterdam (CCA), Amsterdam UMC, VU Medical Center, Amsterdam, the Netherlands. Electronic address: li.smit@vumc.nl.
Publikováno v:
Cell reports [Cell Rep] 2018 Dec 11; Vol. 25 (11), pp. 3021-3035.e5.
Autor:
Chaturvedi N; Afdeling Epidemiologie en Biostatistiek, Amsterdam Public Health Research Institute, Medische Faculteit (F-vleugel), VU Medisch Centrum, 1007 MB Amsterdam, The Netherlands.; Netherlands Bioinformatics Center, 260 NBIC, 6500 HB Nijmegen, The Netherlands., Menezes RX; Afdeling Epidemiologie en Biostatistiek, Amsterdam Public Health Research Institute, Medische Faculteit (F-vleugel), VU Medisch Centrum, 1007 MB Amsterdam, The Netherlands.; Netherlands Bioinformatics Center, 260 NBIC, 6500 HB Nijmegen, The Netherlands., Goeman JJ; Department of Biomedical Data Sciences, Room Number S5-P, LUMC Main Building, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Wieringen WV; Afdeling Epidemiologie en Biostatistiek, Amsterdam Public Health Research Institute, Medische Faculteit (F-vleugel), VU Medisch Centrum, 1007 MB Amsterdam, The Netherlands.; Department of Mathematics, Amsterdam Public Health Research Institute, Faculty of Sciences, Vrije Universiteit, De Boelelaan 1081a, 1081 HV Amsterdam, The Netherlands.
Publikováno v:
Statistical applications in genetics and molecular biology [Stat Appl Genet Mol Biol] 2018 Jul 31; Vol. 17 (5). Date of Electronic Publication: 2018 Jul 31.